Comments on: EyePoint Pharmaceuticals Announces First Patient Dosed in Phase 1 Clinical Trial of EYP-1901 for the Treatment of Wet AMD https://ewhealthcare.com/news/eyepoint-pharmaceuticals-announces-first-patient-dosed-in-phase-1-clinical-trial-of-eyp-1901-for-the-treatment-of-wet-amd/ Fri, 07 Jul 2023 09:23:24 +0000 hourly 1 https://wordpress.org/?v=6.9.4